Top Markets
#1 Islamic Coin Islamic Coin +156.00%
#2 Siren Siren +38.85%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#4 RedStone RedStone +18.90%
#5 Verus Coin Verus Coin +18.06%
#6 Ocean Protocol Ocean Protocol +15.61%
#7 Cysic Cysic +15.47%
#8 OpenEden OpenEden +14.56%
#9 Perle Perle +12.68%
#10 KUB Coin KUB Coin +12.53%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Kedudukan dalam Saham #31814
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Harga Saham
$0.90225185
Disegerakkan terakhir: 2025-02-16
Modal Pasaran
$11.99M
Perubahan (1 hari)
0.48%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Endymed Ltd (ENDY)

Kategori

Healthcare
Nisbah P/E bagi Endymed Ltd (ENDY)
Nisbah P/E pada August 2026 TTM: 27.07
Menurut laporan kewangan dan harga saham terkini Endymed Ltd, nisbah P/E semasa (TTM) ialah 27.07. Pada akhir 2022, syarikat mempunyai nisbah P/E sebanyak 12.14.
Sejarah nisbah P/E bagi Endymed Ltd dari 2013 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 27.07 27.92%
2023 21.16 74.36%
2022 12.14 97.99%
2021 6.13 -84.39%
2020 39.27 779.26%
2019 4.47 39.07%
2018 3.21 -219.36%
2017 -2.69 -34.25%
2016 -4.09 -41.61%
2015 -7.01 -101.83%
2014 383.81 -1,057.98%
2013 -40.06 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 32.17%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 28.80%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -20.98%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -22.79%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 94.49%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.